![Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod - ScienceDirect Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014489406003262-gr4.jpg)
Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod - ScienceDirect
![Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles | Antimicrobial Agents and Chemotherapy Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02419-17/asset/ca1e09b7-8aa1-4d2b-901f-2d7654d8da7e/assets/graphic/zac00518-7138-t01.jpeg)
Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles | Antimicrobial Agents and Chemotherapy
![Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs | SpringerLink Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12639-011-0040-9/MediaObjects/12639_2011_40_Fig1_HTML.gif)
Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs | SpringerLink
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and
![Pharmaceutics | Free Full-Text | Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis | HTML Pharmaceutics | Free Full-Text | Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00516/article_deploy/html/images/pharmaceutics-13-00516-g003-550.jpg)
Pharmaceutics | Free Full-Text | Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis | HTML
![Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis - ScienceDirect Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211320719300545-fx1.jpg)